OrphAI Therapeutics
At OrphAI Therapeutics, we are focused on identifying and developing treatments for rare orphan conditions. Our current clinical stage drug candidates target several orphan disorders including amyotrophic lateral sclerosis (ALS), pulmonary arterial hypertension (PAH) pulmonary sarcoidosis, and bronchiolitis obliterans syndrome (BOS) post lung transplant....
N/A
Technology
Jan 2013
Founded
N/A
Employees
Clinical Development
Industry
Visual (Placeholder)
Profile Information
Name
OrphAI Therapeutics
Industry
Clinical Development
Technology
N/A
Location
Guilford, Connecticut, United States
Founded
Jan 2013
Employees
N/A
Category
Company
Contact Information
Email
joinus@4catalyzer.com
Phone
N/A
Address
N/A